High density lipoprotein from coronary artery disease patients caused abnormal expression of long non-coding RNAs in vascular endothelial cells
Introduction
High density lipoprotein (HDL) is a large complex molecule which contains a variety of proteins, lipids and miRNAs [1], [2], [3]. HDL has been thought to exert protection against cardiovascular disease (CVD) by regulating cholesterol efflux from peripheral tissues, anti-inflammatory and antioxidant, nitric oxide (NO)–promoting function and promoting angiogenesis [4], [5], [6], [7], [8]. Despite epidemiological study had demonstrated that HDL level was inversely associated with cardiovascular risk [9], however, the failures of the clinical trials that designed to raise HDL-C level to reduce the cardiovascular events illustrated that the HDL biological activities or function were more important than its plasma level in diseased conditions [10], [11], [12]. In addition, the studies of genetic variants did not find a positive correlation between the plasma HDL level and coronary artery disease (CAD) [13]. Increased evidence has showed that normal HDL could convert to dysfunctional HDL in diseases states, which regulated vascular endothelial cell function differently [6], [14], [15]. As a result, the efforts to increase plasma HDL level have been transferred to the study and improvement of HDL function.
Long non-coding RNAs (lncRNAs) are a large class of RNAs with length longer than 200 nucleotides, exhibiting alternative spliced and polyadenylated, and many are poorly conserved and species specific [16], [17]. LncRNAs play an extensive role in various important biological processes such as chromatin modification [18], transcriptional and translational regulation [19], and many human diseases [20], [21]. The study of lncRNAs in cardiovascular system is still preliminary. LncRNAs have been identified in cardiomyocytes and vascular endothelial cells and were involved in cardiovascular development and diseases [22], [23], [24]. There are only a few studies investigating the associations between lncRNAs and cholesterol metabolism. Recently, it was reported that a long non-coding natural antisense transcript, APOA1-AS, could negatively regulate the expression of APOA1 through modulating the histone methylation patterns on the chromatin regions flanking the APOA1 gene [25]. Another study has uncovered the interaction between lncRNA and miRNA, in which the RP5-833A20.1 could inhibit the expression of nuclear factor I a (NFIA) by promoting the miR-382-5p expression, ultimately contributing to the regulation of cholesterol homeostasis, inflammatory responses, and foam cell formation [26].
These above studies have suggested a critical role for lncRNAs in the regulation of HDL metabolism and HDL-induced changes of vascular endothelial function. But the details remain unclear. In the present study, lncRNA-sequencing was applied for screening the genome-wide changes of lncRNAs in the cultured human umbilical vein endothelial cells (HUVECs) treated with healthy subjects HDL (n-HDL) and HDL from patients with CAD and hypercholesterolemia (p-HDL). The differential expressions of lncRNAs, genes and mRNAs were examined, and then the relationships among them and their relations with vascular endothelial function were analyzed.
Section snippets
Study population
Patients with CAD and hypercholesterolemia were enrolled. CAD were documented by angiography with the diagnostic criteria of ≥70% stenosis of at least one major coronary vessel caused by atherosclerosis. Patients with valvular heart diseases, congenital heart diseases, diabetes, infectious diseases, severe traumas and receiving operations in early last month were excluded. Healthy adult volunteers were selected as normal controls. All subjects were above 18 years old. This study was approved by
General clinical data of the two groups and their HDL inflammatory index
Except for lipid profile and medications, other characteristics were similar between healthy subjects and patients (Table 1). The proinflammatory index of HDL was evaluated by relative fluorescence units (RFU) and proinflammatory index of HDL in patients with CAD and hypercholesterolemia (RFU: 1821.73 ± 55.44) was much higher than that in healthy subjects (RFU: 888.79 ± 29.29).
RNA-Seq mapped reads, coverage and distribution in the genome
There were more than 100 million of reads obtained in each sample, the number of reads and mapping results were showed (
Discussion
The present study for the first time to our knowledge revealed the molecular events on a genome-wide scale that orchestrated the functions of vascular endothelial cells exposed to HDL from healthy subjects and CAD patients. Our RNA-Seq data revealed that the profiles of lncRNAs, genes and mRNAs were obviously different between n-HDL and p-HDL treated HUVECs. Moreover, KEGG analysis showed that the biological pathways of n-HDL treated cells were quite distinct from that in p-HDL group, with
Conflict of interest
The authors declare that they have no conflict of interest.
Sources of funding
This study was supported by the National Natural Science Foundation of China (81170271, 81370370, 81600382, 81670392, 81570213, 91439125, 81570329 and Distinguished Young Scholar 81325001), the Changjiang Scholars Program from Ministry of Education of China (2014), the Guangdong Pearl River Scholars Program (2012), International cooperation project (2015DFA31070) and National Major Research Program (2016YFC0903000) from the Ministry of Science and Technology of China, Guangdong Natural Science
Acknowledgments
We thank the patients and staffs at the First Affiliated Hospital, Sun Yat-sen University for their assistance throughout this study.
References (44)
Focus on high-density lipoproteins in reducing cardiovascular risk
Am. Heart J.
(2004)- et al.
High density lipoprotein from patients with valvular heart disease uncouples endothelial nitric oxide synthase
J. Mol. Cell Cardiol.
(2014) - et al.
Abnormal high-density lipoprotein induces endothelial dysfunction via activation of toll-like Receptor-2
Immunity
(2013) - et al.
Kcnq1ot1 antisense noncoding RNA mediates lineage-specific transcriptional silencing through chromatin-level regulation
Mol. Cell
(2008) - et al.
A cytoplasmic NF-κB interacting long noncoding RNA Blocks IκB phosphorylation and suppresses Breast cancer metastasis
Cancer Cell
(2015) - et al.
Cytomegalovirus β2.7 RNA transcript protects endothelial cells against apoptosis during ischemia/reperfusion injury
J. Heart Lung Transplant.
(2010) - et al.
Regulation of the apolipoprotein gene cluster by a long noncoding RNA
Cell Rep.
(2014) - et al.
Phosphatidic acid generation through interleukin 2 (IL-2)-induced alpha-diacylglycerol kinase activation is an essential step in IL-2-mediated lymphocyte proliferation
J. Biol. Chem.
(1996) - et al.
CROC-1 encodes a protein which mediates transcriptional activation of the human FOS promoter
Gene
(1997) - et al.
Role of UEV-1A, a homologue of the tumor suppressor protein TSG101, in protection from DNA damage
FEBS Lett.
(1998)
Estimated plasma stearoyl co-A desaturase-1 activity and risk of incident diabetes: the Atherosclerosis Risk in Communities (ARIC) study
Metabolism
Enzymatic activity and genetic variation in SCD1 modulate the relationship between fatty acids and inflammation
Mol. Genet. Metab.
Genetic variation in stearoyl-CoA desaturase 1 is associated with metabolic syndrome prevalence in costa rican adults
J. Nutr.
MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins
Nat. Cell Biol.
Proteomic analysis of high-density lipoprotein
Proteomics
Sphingosine-1-phosphate as a mediator of high-density lipoprotein effects in cardiovascular protection
Cardiovasc. Res.
HDL counterbalance the proinflammatory effect of oxidized LDL by inhibiting intracellular reactive oxygen species rise, proteasome activation, and subsequent NF-kappaB activation in smooth muscle cells
FASEB J.
High density lipoprotein-induced angiogenesis requires the activation of Ras/MAP kinase in human coronary artery endothelial cells
Arterioscler. Thromb. Vasc. Biol.
High-density lipoprotein binding to scavenger receptor-BI activates endothelial nitric oxide synthase
Nat. Med.
Major lipids, apolipoproteins, and risk of vascular disease
JAMA
Effects of dalcetrapib in patients with a recent acute coronary syndrome
New Engl. J. Med.
Effects of torcetrapib in patients at high risk for coronary events
NEW Engl. J. Med.
Cited by (13)
The role of long non-coding RNA ANRIL in the development of atherosclerosis
2022, Non-coding RNA ResearchLncRNA TCONS_00041002 improves neurological outcomes in neonatal rats with hypoxic-ischemic encephalopathy by inhibiting apoptosis and promoting neuron survival
2021, Experimental NeurologyCitation Excerpt :In addition, by constructing the overexpression vector of TCONS_00041002 and the methods of MTT, CCK8 and TUNEL staining, we found overexpression of TCONS_00041002 attenuated cellular apoptosis while facilitates neurite outgrowth, indicating that the recovery of cells is affected by the increase of TCONS_00041002 expression. Many studies have demonstrated that lncRNAs play an important part in biological processes, including cancer metastasis, diagnosis and prognosis, chromatin modification, proliferation, differentiation, cell death, and endothelial cell function (Liu et al., 2017; Xu et al., 2017; Hao et al., 2017; Huang et al., 2017; de Lena et al., 2017; Lu et al., 2017; Sun et al., 2016). Previous evidence has suggested that lncRNAs may play a significant role in the pathogenesis of several neurological diseases.
Implication of long non-coding RNA NEAT1 in the pathogenesis of bacterial meningitis-induced blood-brain barrier damage
2021, Microvascular ResearchCitation Excerpt :Therefore, down-regulation of NEAT1 partially reduced the loss of BBB permeability due to LPS treatment, and hence might alleviate BBB damage in vivo by decreasing the expression of HIF1α. Accumulating evidence strongly indicates that aberrant lncRNAs expression may not only control the biologic processes of tumors, but also have effects on vascular function through modulation of vascular ECs (Evans et al., 2016; Liu et al., 2017). To illustrate the pathogenic mechanisms underlying BBB damage, we evaluated the integrity and permeability of the BBB in a GEC-based in vitro BBB model.
Flavonoid biosynthetic pathways in plants: Versatile targets for metabolic engineering
2020, Biotechnology AdvancesCitation Excerpt :MYB receives intense research interest as it is the main family of the transcription factors that are implicated in inhibition or activation of gene transcription in the plant kingdom. The regulation of anthocyanin, proanthocyanin, flavonol, and other flavonoid biosynthesis is controlled by MYB, which is largely conserved in plants (He et al., 2018; Henry-Kirk et al., 2018; James et al., 2017; Liu et al., 2017a; Sun et al., 2018). The molecular basis involved in the potential post-translational regulatory processes has been narrowly described.
Role of flow-sensitive microRNAs and long noncoding RNAs in vascular dysfunction and atherosclerosis
2019, Vascular PharmacologyEpigenetic mechanisms in coronary artery disease: The current state and prospects
2018, Trends in Cardiovascular MedicineCitation Excerpt :Some novel lncRNAs play essential roles in cardiac function [153]. HUVECs were treated with HDL from healthy subjects and patients with CAD and hypercholesterolemia for 24 h. Different management strategies resulted in different expression levels of lncRNAs, genes and mRNAs, and the differentially expressed lncRNAs impacted the regulation of vascular endothelial function [154]. A lncRNA, necrosis-related factor (NRF), was involved in the regulation of pathological cardiomyocyte apoptosis and the reduction of myocardial ischemia during reperfusion by targeting miR-873 [155].
- 1
These two authors contributed equally to this study.
- 2
Both Zhi-Jun Ou and Jing-Song Ou contributed equally to the design and supervision of the research for this article.